NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-285-2016-2-AU-02 Glypican 2 As A Cancer Marker And Therapeutic Target AU National Stage 2016354440 Issued
NCI E-285-2016-2-PCT-01 Glypican 2 As A Cancer Marker And Therapeutic Target PCT PCT PCT/US2016/060974 Expired
NCI E-234-2010-1-US-08 Biomarkers For Prostate Cancer And Methods For Their Detection. US CON 15/345,634 Abandoned
NCI E-285-2016-2-JP-01 Glypican 2 As A Cancer Marker And Therapeutic Target JP DIV 2023-133443 Pending
NCI E-285-2016-2-JP-07 Glypican 2 As A Cancer Marker And Therapeutic Target JP DIV 2021-194050 Pending
NCI E-285-2016-2-CA-03 Glypican 2 As A Cancer Marker And Therapeutic Target CA National Stage 3004438 Pending
NINDS E-122-2014-0-US-03 Negative Resistance Preamplifier for Inductively Coupled Local MRI Coils US National Stage 15/309,336 10393831 Issued PDF
NHLBI E-034-2016-1-US-01 TSLP Induces Neutrophil Mediated Killing Of Methicillin-resistant Staphylococcus Aureus US ORD 15/345,213 10201591 Issued PDF
NICHD E-210-2021-0-PCT-02 Kits And Methods For Predictions And Treatment Of Preeclampsia PCT PCT PCT/US2016/060825 Expired
NICHD E-209-2021-0-PCT-02 Kits And Methods To Distinguish False Labor And True Labor PCT PCT PCT/US2016/060819 Expired
NCI E-015-2018-1-BR-01 Periodontitis Treatment BR ORD BR1020160262569 Pending
NCI E-055-2017-0-CN-03 Combing D2C7 Immunotoxin With Check Points Inhibitors CN National Stage 2016800708756 Issued
NCI E-055-2017-0-FR-10 Combing D2C7 Immunotoxin With Check Points Inhibitors FR EP 16863025.9 Issued
NCI E-055-2017-0-DE-09 Combing D2C7 Immunotoxin With Check Points Inhibitors DE EP 16863025.9 Issued
NCI E-055-2017-0-GB-11 Combing D2C7 Immunotoxin With Check Points Inhibitors GB EP 16863025.9 Issued
NCI E-055-2017-0-EP-06 Combing D2C7 Immunotoxin With Check Points Inhibitors EP National Stage 16863025.9 Issued
NCI E-156-2014-0-US-03 Triggering RNA Interference With RNA-DNA And DNA-RNA Cube Nanoparticles US National Stage 15/309,157 10517890 Issued PDF
NCI E-055-2017-0-JP-04 Combing D2C7 Immunotoxin With Check Points Inhibitors JP National Stage 2018-543049 Issued
NIAID E-067-2016-3-PCT-01 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation PCT PCT COMB PCT/US2016/060672 Expired
NCI E-055-2017-0-PCT-02 Combing D2C7 Immunotoxin With Check Points Inhibitors PCT PCT PCT/US2016/060469 Expired
NIAID E-133-2015-0-AU-09 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE AU National Stage 2016349392 Issued
NIAID E-133-2015-0-CN-04 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE CN National Stage 201680077520.X Issued
NIAID E-133-2015-0-PCT-02 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE PCT PCT PCT/US2016/060390 Expired
NIAID E-133-2015-0-EP-05 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE EP National Stage 16801639.2 Abandoned
NIAID E-133-2015-0-CA-03 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE CA National Stage 3003878 Pending
NIAID E-133-2015-0-ZA-08 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE ZA National Stage 2018/02875 Pending
NLM E-107-2010-2-US-05 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US National Stage 15/341,344 10533213 Issued PDF
NINDS E-155-2006-0-US-14 Novel Neuroactive Steroids US CON 15/341,573 10087211 Issued PDF
NINDS E-121-2014-0-US-06 Miniature Serial Sectioning Microtome for Block-Face Imaging US National Stage 15/308,522 9933339 Issued PDF
NIA E-092-2011-0-US-09 THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND
OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE
IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN 		US CON 15/341,784 9867830 Issued PDF
NIDDK E-038-2016-0-PCT-02 IGF2BP1 AND/OR IGF2BP3 FOR TREATMENT PCT PCT PCT/US16/060084 Expired
NCI E-035-2016-0-PCT-02 METHODS OF PRODUCING T CELL POPULATIONS USING PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN INHIBITORS PCT PCT PCT/US2016/059834 Abandoned
NCI E-187-2015-0-AU-05 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors AU National Stage 2016343845 Issued
NCI E-187-2015-0-JP-04 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors JP National Stage 2018-521518 Issued
NCI E-187-2015-0-EP-06 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors EP National Stage 16795498.1 Issued
NCI E-187-2015-0-GB-10 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors GB EP 16795498.1 Issued
NCI E-187-2015-0-DE-08 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors DE EP 16795498.1 Issued
NCI E-187-2015-0-FR-09 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors FR EP 16795498.1 Issued
NIAID E-154-2010-1-US-04 CHIMPANZEE ADENOVIRAL VECTOR-BASED EILOVIRUS VACCINES US DIV 15/339,225 10584355 Issued PDF
NCI E-187-2015-0-PCT-02 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors PCT PCT PCT/US2016/059680 Expired
NCI E-187-2015-0-CA-03 Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors CA National Stage 3002685 Pending
NIBIB E-079-2011-1-US-03 Imaging Agents For Imaging Protease Activity And Uses Thereof US DIV 15/337,461 10646591 Issued PDF
NCI E-109-2016-0-PCT-02 TARGETED CANCER THERAPY PCT PCT PCT/US2016/059452 Expired
NCI E-109-2016-0-HK-13 TARGETED CANCER THERAPY HK EP 19101252.0 Pending
NCI E-109-2016-0-CN-07 TARGETED CANCER THERAPY CN National Stage 201680077320.4 Pending
NCI E-109-2016-0-EP-08 TARGETED CANCER THERAPY EP National Stage 16860932.9 Pending
NCI E-108-2016-0-PCT-02 TARGETED CANCER THERAPY PCT PCT PCT/US16/059388 Expired
NCI E-109-2016-0-MX-12 TARGETED CANCER THERAPY MX National Stage MX/A/2018/005468 Pending
NCI E-109-2016-0-JP-10 TARGETED CANCER THERAPY JP National Stage 2018-542994 Pending
NCI E-109-2016-0-KR-11 TARGETED CANCER THERAPY KR National Stage 10-2018-7014629 Pending